| UniProt ID | RGPS2_HUMAN | |
|---|---|---|
| UniProt AC | Q86X27 | |
| Protein Name | Ras-specific guanine nucleotide-releasing factor RalGPS2 | |
| Gene Name | RALGPS2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 583 | |
| Subcellular Localization | Cytoplasm. Cell membrane. Associates with membranes through the PH domain.. | |
| Protein Description | Guanine nucleotide exchange factor for the small GTPase RALA. May be involved in cytoskeletal organization. May also be involved in the stimulation of transcription in a Ras-independent fashion (By similarity).. | |
| Protein Sequence | MDLMNGQASSVNIAATASEKSSSSESLSDKGSELKKSFDAVVFDVLKVTPEEYAGQITLMDVPVFKAIQPDELSSCGWNKKEKYSSAPNAVAFTRRFNHVSFWVVREILHAQTLKIRAEVLSHYIKTAKKLYELNNLHALMAVVSGLQSAPIFRLTKTWALLSRKDKTTFEKLEYVMSKEDNYKRLRDYISSLKMTPCIPYLGIYLSDLTYIDSAYPSTGSILENEQRSNLMNNILRIISDLQQSCEYDIPMLPHVQKYLNSVQYIEELQKFVEDDNYKLSLKIEPGTSTPRSAASREDLVGPEVGASPQSGRKSVAAEGALLPQTPPSPRNLIPHGHRKCHSLGYNFIHKMNTAEFKSATFPNAGPRHLLDDSVMEPHAPSRGQAESSTLSSGISIGSSDGSELSEETSWPAFERNRLYHSLGPVTRVARNGYRSHMKASSSAESEDLAVHLYPGAVTIQGVLRRKTLLKEGKKPTVASWTKYWAALCGTQLFYYAAKSLKATERKHFKSTSNKNVSVIGWMVMMADDPEHPDLFLLTDSEKGNSYKFQAGNRMNAMLWFKHLSAACQSNKQQVPTNLMTFE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 9 | Phosphorylation | DLMNGQASSVNIAAT CCCCCCCCCCEEEEE | 27.25 | 20068231 | |
| 10 | Phosphorylation | LMNGQASSVNIAATA CCCCCCCCCEEEEEC | 23.38 | 20068231 | |
| 21 | Phosphorylation | AATASEKSSSSESLS EEECCCCCCCCCCCC | 31.25 | 23403867 | |
| 22 | Phosphorylation | ATASEKSSSSESLSD EECCCCCCCCCCCCH | 49.29 | 23403867 | |
| 23 | Phosphorylation | TASEKSSSSESLSDK ECCCCCCCCCCCCHH | 45.26 | 26055452 | |
| 24 | Phosphorylation | ASEKSSSSESLSDKG CCCCCCCCCCCCHHH | 32.90 | 23403867 | |
| 26 | Phosphorylation | EKSSSSESLSDKGSE CCCCCCCCCCHHHHH | 34.81 | 25849741 | |
| 28 | Phosphorylation | SSSSESLSDKGSELK CCCCCCCCHHHHHHH | 46.70 | 23403867 | |
| 32 | Phosphorylation | ESLSDKGSELKKSFD CCCCHHHHHHHHHHC | 45.56 | 23403867 | |
| 37 | Phosphorylation | KGSELKKSFDAVVFD HHHHHHHHHCEEEEE | 27.11 | 30278072 | |
| 79 | Ubiquitination | ELSSCGWNKKEKYSS HHHCCCCCCHHHCCC | 30.70 | 23000965 | |
| 83 | Ubiquitination | CGWNKKEKYSSAPNA CCCCCHHHCCCCCCE | 60.35 | 23000965 | |
| 84 | Phosphorylation | GWNKKEKYSSAPNAV CCCCHHHCCCCCCEE | 14.67 | 28258704 | |
| 86 | Phosphorylation | NKKEKYSSAPNAVAF CCHHHCCCCCCEEHH | 44.66 | 28258704 | |
| 94 | Phosphorylation | APNAVAFTRRFNHVS CCCEEHHHHCCCCHH | 15.93 | 28258704 | |
| 101 | Phosphorylation | TRRFNHVSFWVVREI HHCCCCHHHHHHHHH | 13.07 | 28258704 | |
| 122 | Phosphorylation | KIRAEVLSHYIKTAK HHHHHHHHHHHHHHH | 21.30 | 28258704 | |
| 124 | Phosphorylation | RAEVLSHYIKTAKKL HHHHHHHHHHHHHHH | 10.75 | 20068231 | |
| 158 | Phosphorylation | PIFRLTKTWALLSRK CHHHHHHHHHHHCCC | 15.67 | - | |
| 175 | Phosphorylation | TTFEKLEYVMSKEDN CHHHHHHHHHCCCHH | 16.34 | 23663014 | |
| 178 | Phosphorylation | EKLEYVMSKEDNYKR HHHHHHHCCCHHHHH | 23.89 | 23663014 | |
| 183 | Phosphorylation | VMSKEDNYKRLRDYI HHCCCHHHHHHHHHH | 15.14 | 23663014 | |
| 191 | Phosphorylation | KRLRDYISSLKMTPC HHHHHHHHHCCCCCC | 24.32 | 24719451 | |
| 259 | Phosphorylation | MLPHVQKYLNSVQYI CHHHHHHHHHHHHHH | 8.27 | 22817900 | |
| 265 | Phosphorylation | KYLNSVQYIEELQKF HHHHHHHHHHHHHHH | 14.24 | 22817900 | |
| 271 | Ubiquitination | QYIEELQKFVEDDNY HHHHHHHHHHHCCCE | 65.09 | - | |
| 278 | Phosphorylation | KFVEDDNYKLSLKIE HHHHCCCEEEEEEEC | 21.94 | - | |
| 279 | Ubiquitination | FVEDDNYKLSLKIEP HHHCCCEEEEEEECC | 37.54 | 23000965 | |
| 281 | Phosphorylation | EDDNYKLSLKIEPGT HCCCEEEEEEECCCC | 24.38 | 24719451 | |
| 283 (in isoform 1) | Ubiquitination | - | 41.47 | 21906983 | |
| 283 | Ubiquitination | DNYKLSLKIEPGTST CCEEEEEEECCCCCC | 41.47 | 21906983 | |
| 283 | Ubiquitination | DNYKLSLKIEPGTST CCEEEEEEECCCCCC | 41.47 | 23000965 | |
| 288 | Phosphorylation | SLKIEPGTSTPRSAA EEEECCCCCCCCCCC | 39.89 | 29255136 | |
| 289 | Phosphorylation | LKIEPGTSTPRSAAS EEECCCCCCCCCCCC | 42.18 | 29255136 | |
| 290 | Phosphorylation | KIEPGTSTPRSAASR EECCCCCCCCCCCCH | 23.66 | 25849741 | |
| 293 | Phosphorylation | PGTSTPRSAASREDL CCCCCCCCCCCHHHC | 29.41 | 23927012 | |
| 296 | Phosphorylation | STPRSAASREDLVGP CCCCCCCCHHHCCCC | 35.60 | 19664994 | |
| 308 | Phosphorylation | VGPEVGASPQSGRKS CCCCCCCCCCCCCCC | 19.97 | 19664994 | |
| 311 | Phosphorylation | EVGASPQSGRKSVAA CCCCCCCCCCCCHHH | 43.90 | 30266825 | |
| 315 | Phosphorylation | SPQSGRKSVAAEGAL CCCCCCCCHHHCCCC | 18.67 | 29255136 | |
| 326 | Phosphorylation | EGALLPQTPPSPRNL CCCCCCCCCCCCCCC | 34.92 | 29255136 | |
| 329 | Phosphorylation | LLPQTPPSPRNLIPH CCCCCCCCCCCCCCC | 37.38 | 19664994 | |
| 343 | Phosphorylation | HGHRKCHSLGYNFIH CCCHHCHHCCCHHHH | 32.72 | 23401153 | |
| 346 | Phosphorylation | RKCHSLGYNFIHKMN HHCHHCCCHHHHCCC | 16.52 | 23927012 | |
| 354 | Phosphorylation | NFIHKMNTAEFKSAT HHHHCCCHHHHHHCC | 24.86 | 27251275 | |
| 358 | Methylation | KMNTAEFKSATFPNA CCCHHHHHHCCCCCC | 30.59 | 115976155 | |
| 359 | Phosphorylation | MNTAEFKSATFPNAG CCHHHHHHCCCCCCC | 37.55 | 30266825 | |
| 361 | Phosphorylation | TAEFKSATFPNAGPR HHHHHHCCCCCCCCC | 46.87 | 23401153 | |
| 374 | Phosphorylation | PRHLLDDSVMEPHAP CCCCCCCCCCCCCCC | 24.03 | 29255136 | |
| 382 | Phosphorylation | VMEPHAPSRGQAESS CCCCCCCCCCCCCCC | 50.23 | 29255136 | |
| 420 | Phosphorylation | AFERNRLYHSLGPVT HHHHCCHHHHCCHHH | 6.02 | 21945579 | |
| 422 | O-linked_Glycosylation | ERNRLYHSLGPVTRV HHCCHHHHCCHHHHH | 22.82 | OGP | |
| 422 | Phosphorylation | ERNRLYHSLGPVTRV HHCCHHHHCCHHHHH | 22.82 | 21945579 | |
| 427 | Phosphorylation | YHSLGPVTRVARNGY HHHCCHHHHHHHCCH | 23.66 | 29255136 | |
| 441 | Phosphorylation | YRSHMKASSSAESED HHHHCCCCCCCCCCC | 21.21 | 28348404 | |
| 442 | Phosphorylation | RSHMKASSSAESEDL HHHCCCCCCCCCCCC | 38.13 | 28348404 | |
| 443 | Phosphorylation | SHMKASSSAESEDLA HHCCCCCCCCCCCCC | 33.29 | 28348404 | |
| 446 | Phosphorylation | KASSSAESEDLAVHL CCCCCCCCCCCCHHH | 35.81 | 28348404 | |
| 477 | Phosphorylation | LKEGKKPTVASWTKY HHCCCCCCCHHHHHH | 37.27 | - | |
| 511 | Phosphorylation | TERKHFKSTSNKNVS HHHHHHHCCCCCCEE | 35.80 | - | |
| 512 | Phosphorylation | ERKHFKSTSNKNVSV HHHHHHCCCCCCEEE | 36.59 | - | |
| 513 | Phosphorylation | RKHFKSTSNKNVSVI HHHHHCCCCCCEEEE | 53.55 | - | |
| 539 | Phosphorylation | HPDLFLLTDSEKGNS CCCEEEEECCCCCCE | 39.36 | 30576142 | |
| 546 | Phosphorylation | TDSEKGNSYKFQAGN ECCCCCCEEEECCCC | 38.07 | 30576142 | |
| 548 | Ubiquitination | SEKGNSYKFQAGNRM CCCCCEEEECCCCCC | 30.71 | - | |
| 548 | Malonylation | SEKGNSYKFQAGNRM CCCCCEEEECCCCCC | 30.71 | 26320211 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RGPS2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RGPS2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RGPS2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| 1433Z_HUMAN | YWHAZ | physical | 28514442 | |
| 1433G_HUMAN | YWHAG | physical | 28514442 | |
| CING_HUMAN | CGN | physical | 27173435 | |
| KI13B_HUMAN | KIF13B | physical | 27173435 | |
| GGYF2_HUMAN | GIGYF2 | physical | 27173435 | |
| GGYF1_HUMAN | GIGYF1 | physical | 27173435 | |
| CBY1_HUMAN | CBY1 | physical | 27173435 | |
| LRFN1_HUMAN | LRFN1 | physical | 27173435 | |
| NADK_HUMAN | NADK | physical | 27173435 | |
| HDAC4_HUMAN | HDAC4 | physical | 27173435 | |
| SI1L1_HUMAN | SIPA1L1 | physical | 27173435 | |
| NGAP_HUMAN | RASAL2 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293; SER-296; SER-308;THR-326 AND SER-329, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308; SER-311; THR-326AND SER-329, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-422, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-326; SER-329 ANDSER-343, AND MASS SPECTROMETRY. | |